223 related articles for article (PubMed ID: 16092968)
1. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
Nayak SB; Bhaktha G
Lipids Health Dis; 2005 Aug; 4():15. PubMed ID: 16092968
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
3. Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
Shivananda Nayak B; Duncan H; Lalloo S; Maraj K; Matmungal V; Matthews F; Prajapati B; Samuel R; Sylvester P
Vasc Health Risk Manag; 2008; 4(1):243-7. PubMed ID: 18629366
[TBL] [Abstract][Full Text] [Related]
4. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Nawab SN; Shaikh R; Mahboob T
Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
[TBL] [Abstract][Full Text] [Related]
6. Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications.
Nayak BS; Roberts L
J Inflamm (Lond); 2006 Dec; 3():17. PubMed ID: 17187674
[TBL] [Abstract][Full Text] [Related]
7. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
8. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Yokoyama H; Jensen JS; Jensen T; Deckert T
J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
Deepa R; Rema M; Mohan V
Diabetes Res Clin Pract; 1998 Sep; 41(3):165-9. PubMed ID: 9829344
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Jawed M; Mahboob T
Pak J Pharm Sci; 2013 May; 26(3):593-7. PubMed ID: 23625435
[TBL] [Abstract][Full Text] [Related]
12. Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
Islam N; Kazmi F; Chusney GD; Mattock MB; Zaini A; Pickup JC
Diabetes Care; 1998 Mar; 21(3):385-8. PubMed ID: 9540020
[TBL] [Abstract][Full Text] [Related]
13. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
Crook MA; Tutt P; Pickup JC
Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
[TBL] [Abstract][Full Text] [Related]
15. Serum sialic acid in young type-1 diabetic patients.
Crook M; Cartwright K; Lumb P; Worsley A
Diabetes Res Clin Pract; 2000 Feb; 47(2):119-22. PubMed ID: 10670911
[TBL] [Abstract][Full Text] [Related]
16. Monitoring Diabetic Nephropathy by Circulating Gangliosides.
Ene CD; Penescu M; Anghel A; Neagu M; Budu V; Nicolae I
J Immunoassay Immunochem; 2016; 37(1):68-79. PubMed ID: 26359623
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.
Roozbeh J; Merat A; Bodagkhan F; Afshariani R; Yarmohammadi H
Int Urol Nephrol; 2011 Dec; 43(4):1143-8. PubMed ID: 21207147
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].
Spunda J; Neumann M; Bartásková D; Kvapil M
Cas Lek Cesk; 1996 Nov; 135(22):723-5. PubMed ID: 8998824
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
Pradeepa R; Anjana RM; Unnikrishnan R; Ganesan A; Mohan V; Rema M
Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
[TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
